Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Licenses Orchid s SNP-IT Tech

NEW YORK, Jan. 31 - Beckman Coulter has secured a nonexclusive license to Orchid BioSciences' SNP primer-extension system, the two companies said on Thursday.

 

Under the terms of the agreement, Beckman Coulter can incorporate Orchid's SNP-IT scoring technique into reagent kits, software, and SNP scoring products for international distribution. This technology can be adapted to DNA sequencer, microarray plates, or flow cytometers.

 

As part of the deal, Orchid will get an upfront payment, as well as royalties on sales of consumable products. Other financial details were not disclosed.

 

As part of a separate arrangement, Orchid acquired all rights to a Beckman patent for solid-phase sequencing through progressive primer extension, a technique that can be used to identify more than one SNP on a DNA sample.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.